Two Vaccines Making News Tuesday. Johnson & Johnson Is Temporarily Halting Use Of Theirs While Pfizer Cranks Up Production.

IMAGE DISTRIBUTED FOR TYSON FOODS - Tyson Foods team members receive Covid-19 vaccines from health officials at the Wilkesboro, N.C. facility on Wednesday, Feb. 3, 2021. The team members are eligible for the vaccine under North Carolina's Phase 2 distribution which include residents 65 and older. Tyson and its partner Matrix Medical will deploy mobile health clinics and expert clinical staff to support vaccine access and education at its facilities. (Melissa Melvin/AP Images for Tyson Foods)

News of  the administering of Johnson & Johnson’s COVID vaccine was being shut down in numerous states across the  U.S. dominated the morning on Tuesday, but later in the day Pfizer made an announcement that they will be able to increase their production. 

CEO Albert Bourla said they have the capability to deliver a total of 300 million doses to the U.S., which is 10% more than they had agreed to deliver by the end of May. 

Essentially, they will deliver the entire amount two weeks early. 

The reason for Johnson & Johnson’s shutdown was the fact six women have developed a rare blood clotting disorder.  One of the women has died from it, and another is in critical condition. 

There should be plenty of shots provided by Pfizer and Moderna to accommodate everyone that wants a shot in the U.S.  Both companies have said they have the capability to deliver 300 million shots by the end of July. 

New York is one state that will now switch to Pfizer for their vaccine in place of Johnson & Johnson. 

Join the conversation!

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please hover over that comment, click the ∨ icon, and mark it as spam. Thank you for partnering with us to maintain fruitful conversation.